Early phase clinical trials often need more than standard safety data. In Phase 0, Phase I and Phase II studies, sponsors, CROs and research teams may also need to understand how a treatment affects immune activity, inflammation or disease related biological pathways. Cytokine testing for clinical trials can support this work by helping researchers measure […]
Introduction: The Scientific Need for Multiplex Strategies Advances in biomarker technologies have transformed how researchers investigate immune responses, disease biology, and therapeutic mechanisms. Traditional single-analyte assays, such as ELISA, remain valuable tools for focused questions. However, complex biological systems rarely operate through a single pathway or molecule. Instead, networks of cytokines, chemokines, and other signaling […]
Introduction Cancer immunotherapies harness the patient’s immune system, but individual responses vary widely. Measuring cytokines – small immune‐signaling proteins – can reveal how a patient’s immune system is reacting to therapy. Measuring cytokines such as interleukin‑6 (IL‑6) and interferon‑γ (IFN‑γ) reveals critical biomarkers involved in anti‑tumor activity, while their dysregulated release can cause life‑threatening cytokine […]
Understanding the immune system often begins with one powerful tool: cytokine profiling. Whether you’re studying inflammation, autoimmune disease, cancer immunotherapy, or vaccine responses, cytokine measurements offer a real-time view into immune activity. But with so many options available, selecting the right multiplex immune assay can be a challenge. This article compares three widely used platforms […]
Introduction In the rapidly advancing world of biomedical research, efficient and precise data collection is crucial. As the demand for comprehensive insights into complex biological systems increases, researchers are turning to multiplex assays powered by Luminex platform. This breakthrough platform allows scientists to analyze multiple biomarkers in a single sample, accelerating the pace of discovery […]